Comparative study of some treatment modalities of rosacea

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 1, 2009, Pages 22-28

  Mostafa, F F ^a   El Harras, M A ^a   Gomaa, S M ^a   Al Mokadem, S ^a   Nassar, A A ^a   Abdel Gawad, E H ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Azelaic acid; Metronidazole; Permethrin; Rosacea

Indexed keywords

AZELAIC ACID; METRONIDAZOLE; PERMETHRIN;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; ROSACEA; SKIN DISEASE; SKIN SCALING; TREATMENT OUTCOME;

ADULT; DICARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; PERMETHRIN; ROSACEA;

EID: 57649180129     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02940.x     Document Type: Article

References (31)

1. Bamford JT. Rosacea: current thoughts on origin. Sem Cutan Med Surg 2001 20 : 199 206.
2. Blount BW, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Acad Fam Phys 2002 66 : 435 440.
3. Dahl MV. Pathogenesis of rosacea. Adv Dermatol 2001 17 : 29 45.
4. Dahl MV, Ross AJ, Schlievert, PM. Temperature regulates bacterial protein production: possible role in rosacea. J Am Acad Dermatol 2004 50 : 266 272.
5. Forton F, Seys B. Density of Demodex folliculorum in rosacea; a case - control study using standardized skin-surface biopsy. Br J Dermatol 1993 128 : 650 659.
6. Abd El-Al AM, Bayoumy AM, Abou Salem EA. A study on Demodex folliculorum in rosacea. J Egypt Soc Parasitol 1997 27 : 183 185.
7. Utas S, Ozbakir O, Turasan A, Utas C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol 1999 40 : 3433 3435.
8. Crawford G, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis and subtype classification. J Am Acad Dermatol 2004 51 : 327 341.
9. Diamantis S, Waldorf HA. Rosacea: clinical presentation and pathophysiology. J Drugs Dermatol 2006 5 : 8 12.
10. Wilkin JK, Dahl M, Detmar M et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004 50 : 907 912.
11. Van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S. Systematic review of rosacea treatments. J Am Acad Dermatol 2007 56 : 107 115.
12. Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 2001 45 : 723 730.
13. Baldwin HE. Systemic therapy for rosacea. Skin Therapy Lett 2007 12 : 1 5.
14. Gupta AK, Gover MD. Azelaic acid (15% gel) in the treatment of acne rosacea. Int J Dermatol 2007 46 : 533 538.
15. Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J Eur Acad Dermatol Venereol 2005 19 : 273 285.
16. Forstinger C, Kittler H, Binder M. Treatment of rosacea like demodicidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol 1999 41 : 775 777.
17. Slawson D. Permethrin cream useful in the treatment of rosacea. Am Acad Fam Phys 2003 67 : 1782 1784.
18. Kaufmann R. Lasers in dermatology - State of the art. Med Laser Application 2005 20 : 103 110.
19. McCoy S, Hanna M, Anderson P, McLennan G, Repacholi M. An evaluation of the copper-bromide laser for treating telangiectasia. Dermatol Surg 1996 22 : 551 557.
20. Railan D, Parlette C, Uebelhoer S, Rofrer TE. Laser treatment of vascular lesions. Clin Dermatol 2006 24 : 8 15.
21. Laube S, Lanigan SW. Laser treatment of rosacea. J Cosmdermatol 2002 1 : 188.
22. Bassichis AB, Swamy BA, Dayan HS. Use of the KTP Laser in the Treatment of rosacea and solar lentigines. Fac Plast Surg 2004 20 : 77 83.
23. Thiboutot DM, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea. Results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 2003 48 : 836 845.
24. Elewski BE, Fleischer AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea. Results of a randomized trial. Arch Dermatol 2003 139 : 1444 1450.
25. Van Zuuren EJ, Graber MA. The rigor of trials evaluating rosacea treatments. Cutis 2005 75 : 13 16.
26. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 1999 40 : 961 965.
27. Del Rosso JQ, Baum EW, Draelos ZD et al. Azelaic acid gel 15%: clinical versatility in the treatment of rosacea. Cutis 2007 78 : 6 19.
28. Kocak M, Yagli S, Vahapoglu G, Eksioglu M. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. Dermatology 2002 205 : 265 270.
29. Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin Pharmacother 2004 5 : 5 13.
30. Wolf JE, Del Rosso JQ. The clear trial: results of a large community-based study of metronidazole gel in rosacea. Cutis 2007 79 : 73 80.
31. Colon LE, Johnson LA, Gottschalk, R.W. Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid Gel 15%. Cutis 2007 79 : 317 321.